All filters
Slidesets
Serum cystatine as a marker for estimated glomerular filtration rate (eGFR) assessment in HIV-1-infected patients with dolutegravir-based antiretroviral therapy (ART).- R. Palich
Presented at:
European HIV Clinical Forum 2017
Slidesets
Clinical case presentation- Miłosz Parczewski, MD, PhD
Presented at:
European HIV Clinical Forum 2017
Slidesets
Evolution of bone mineral density and MDRD in HIV-infected patients treated with dolutegravir based regimens: results at 48- weeks- A. D'Avino
Presented at:
European HIV Clinical Forum 2017
Slidesets
Prospects of immunotherapy for treatment- Michael Lederman, MD
Presented at:
European HIV Clinical Forum 2017
Slidesets
One pill a day?: Integration novel delivery systems into routine care- Giovanni Di Perri, MD, PhD
Presented at:
European HIV Clinical Forum 2017
Slidesets
TAF – The latest update, which questions remain to be answered?- Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Hepatitis B Cure: From Discovery to Regulatory Endpoints in HBV clinical research: A summary of the AASLD/EASL statement- Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
How does HBV interact with the immune system- Mala Maini, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Is immunomodulation really needed to cure HBV?- Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Innate Immunity : TLR, RIG-I, STING and potential others- Adam Gehring, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Adaptive Immunity: Therapeutic vaccination, checkpoint inhibition and potential others- Andre Boonstra, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Entry inhibition- Stephan Urban, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
CCC – DNA inhibition- Anuj Gaggar, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
RNA interference- Bill Symonds, PharmD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Other virological mechanisms- Stephen Locarnini, BSc, PhD, MBBS, FRCP
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Innovative trial design- Henry Lik Yuen Chan
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Combination therapy how to navigate in a minefield of efficacy and toxicity?- Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Understanding complexities of gut microbiome dysbiosis in HIV infected populations using a large cohor- Abigail Armstrong
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Differential responses of colonic ILCs to gut commensal bacteria altered during HIV infection- Moriah Castleman, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Milk - guiding the infant microbiome - Bruce German, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
The microbial-derived short chain fatty acid butyrate directly and differentially inhibits gut T helper cell subset activation and proliferation- Jon Kibbie
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Opening Lecture: Brain-Gut-Microbiota interactions and intestinal health- Wendy Henderson, PhD, MSN, CRNP
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Role of the microbiome in HIV vaccine response heterogeneity- James Kublin, MD, MPH
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017